LEADER 01932nam 2200397 n 450 001 996393183103316 005 20200824121725.0 035 $a(CKB)4940000000112229 035 $a(EEBO)2240942324 035 $a(UnM)99871535e 035 $a(UnM)99871535 035 $a(EXLCZ)994940000000112229 100 $a19860124d1646 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 10$aMr. Peters last report of the English vvars$b[electronic resource] $eoccasioned by the importunity of a friend pressing an answer to seven quæres. Viz. [brace] I. Why he was silent at the surrender of Oxford. II. What he observed at Worcester it being the last towne in the Kings hand. III. What were best to doe with the Army. IV. If he had any expedient for the present difference. V. What his thoughts were in relation to forreigne states. VI. How these late mercies and conquests might be preserved and improved. VII. Why his name appeares in so many bookes not without blots, and he never wipe them off. Published by authority 210 $aLondon, $cPrinted by M.S. for Henry Overton, and are to be sold at his shop in Popes-Head Alley.$d1646 215 $a15, [1] p 300 $aThe words "I. Why he was .. wipe them off." are bracketed together on title page. 300 $aAnnotation on Thomason copy: "Aug 27". 300 $aReproduction of original in the British Library. 330 $aeebo-0018 606 $aRegicides$vEarly works to 1800 606 $aCongregationalism$vEarly works to 1800 607 $aGreat Britain$xHistory$yCivil War, 1642-1649$vEarly works to 1800 615 0$aRegicides 615 0$aCongregationalism 700 $aPeters$b Hugh$f1598-1660.$01001807 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bWaOLN 906 $aBOOK 912 $a996393183103316 996 $aMr. Peters last report of the English vvars$92333175 997 $aUNISA LEADER 04818nam 22007334a 450 001 9911020256203321 005 20200520144314.0 010 $a9786611788025 010 $a9781281788023 010 $a1281788023 010 $a9780470386385 010 $a047038638X 010 $a9780470386378 010 $a0470386371 035 $a(CKB)1000000000540925 035 $a(EBL)468844 035 $a(OCoLC)264703252 035 $a(SSID)ssj0000176955 035 $a(PQKBManifestationID)11153821 035 $a(PQKBTitleCode)TC0000176955 035 $a(PQKBWorkID)10210759 035 $a(PQKB)11071722 035 $a(MiAaPQ)EBC468844 035 $a(PPN)242640702 035 $a(Perlego)2762239 035 $a(EXLCZ)991000000000540925 100 $a20080402d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aImmunotoxicology strategies for pharmaceutical safety assessment /$fedited by Danuta J. Herzyk and Jeanine L. Bussiere 210 $aHoboken, N.J. $cWiley$dc2008 215 $a1 online resource (432 p.) 300 $aDescription based upon print version of record. 311 08$a9780470122389 311 08$a0470122382 320 $aIncludes bibliographical references and index. 327 $aCurrent regulatory expectations for immunotoxicologyy evaluation of pharmaceuticals / Kenneth L. Hastings -- Clinical pathology as crucial insight into immunotoxicity testing / Ellen Evans -- Histomorphology of the immune system : a basic step in assessing immunotoxicity / Patrick Haley -- 327 $aNeed for specialized immunotoxicity tests / Kazuichi Nakamura -- Specific drug-induced immunotoxicity : immune-mediated hemolytic anemia / Raj Krishnaraj -- T cell-dependent antibody response tests / Joseph R. Piccotti -- Natural killer cell assay and other innate immunity tests / Lisa Plitnick -- Cellular immune response in delayed-type hypersensitivity test / Karen Price -- Evaluation of drug effects on immune cell phenotypes / Laurie Iciek -- 327 $aFunctional cellular responses and cytokine profiles / Elizabeth R. Gore -- Application of flow cytometry in drug development / Padma Narayanan ... [et al.] -- Animal models of host resistance / Gary R. Burleson and Florence G. Burleson -- Approaches to evaluation of autoimmunity / Danuta J. Herzyk -- 327 $aDifferentiating between desired immunomodulation and potential immunotoxicity / Jeanine L. Bussiere and Barbara Mounho -- Relevant immune tests across different species and surrogate models / Jeanine L. Bussiere -- Antidrug antibody responses in nonclinical studies and their implications / Barbara Mounho -- Pharmacological immunogenicity and adverse responses to vaccines / Mary Kate Hart, Mark Bolanowski, and Robert V. House -- 327 $aImmunotoxicological concerns for vaccines and adjuvants / Catherine Kaplanski ... [et al.] -- Systemic hypersensitivity / Raymond Pieters -- Nonclinical models to assess respiratory hypersensitivity potential / Curtis C. Maier -- Developmental immunotoxicity in rodents / Rodney R. Dietert and Leigh Ann Burns-Naas -- Developmental immunotoxicity in nonhuman primates / Pauline L. Martin and Eberhard Buse -- 327 $aAlternative animal models for immunomodulation and immunotoxicity / Peter J. Bugelski -- Animal models for preclinical comparative immunogenicity testing / Daniel Wierda -- T cell epitopes and minimization of immunogenicity / Harald Kropshoffer and Thomas Singer -- Bridging immunotoxicology to clinical drug development / Ian Gourley and Jacques Descotes. 330 $aAn important reference which provides an overview of the current and recently introduced methodologies for testing the immunotoxic risks in drug candidatesHelps readers understand the significance of the methods and approaches to immunotoxicology testingAids drug scientists in industry and regulatory areas to consolidate approaches to immunotox testingOffers a definitive assessment of nonclinical models to study the toxic impacts (bio)pharmaceuticals can have on the immune systemIncludes chapter authors from across the ph 606 $aImmunotoxicology 606 $aImmune system$xEffect of drugs on 606 $aToxicity testing 606 $aDrugs$xToxicology 615 0$aImmunotoxicology. 615 0$aImmune system$xEffect of drugs on. 615 0$aToxicity testing. 615 0$aDrugs$xToxicology. 676 $a616.97/071 701 $aHerzyk$b Danuta J$01841882 701 $aBussiere$b Jeanine L$01841883 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911020256203321 996 $aImmunotoxicology strategies for pharmaceutical safety assessment$94421773 997 $aUNINA LEADER 03319nam 22008532 450 001 9910973361603321 005 20251116150735.0 010 $a0-19-028728-4 010 $a0-19-772033-1 010 $a9786610481149 010 $a1-280-48114-5 010 $a1-282-36714-5 010 $a9786612367144 010 $a0-19-803183-1 010 $a0-19-534902-4 010 $a0-19-530303-2 024 7 $a10.1093/oso/9780195139075.001.0001 035 $a(CKB)1000000000029058 035 $a(EBL)439056 035 $a(OCoLC)609840204 035 $a(SSID)ssj0000234994 035 $a(PQKBManifestationID)11229301 035 $a(PQKBTitleCode)TC0000234994 035 $a(PQKBWorkID)10246581 035 $a(PQKB)11492183 035 $a(Au-PeEL)EBL439056 035 $a(CaPaEBR)ebr10085223 035 $a(CaONFJC)MIL236714 035 $a(Au-PeEL)EBL4964380 035 $a(CaONFJC)MIL48114 035 $a(OCoLC)59280397 035 $a(OCoLC)1406788047 035 $a(StDuBDS)9780197720332 035 $a(MiAaPQ)EBC439056 035 $a(MiAaPQ)EBC4964380 035 $a(EXLCZ)991000000000029058 100 $a20010721e20232001 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aRegulating tobacco /$fedited by Robert L. Rabin and Stephen D. Sugarman 210 1$aNew York ;$cOxford University Press,$d2023. 215 $a1 online resource (310 p.) 225 1 $aOxford scholarship online 300 $aIncludes index. 300 $aPreviously issued in print: 2001. 311 08$a0-19-513907-0 311 08$a0-19-514756-1 320 $aIncludes bibliographical references and index. 327 $aContents; About the Contributors; 1 Perspectives on Policy: Introduction; 2 The Politics of Tobacco Regulation in the United States; 3 Taxing Tobacco: The Impact of Tobacco Taxes on Cigarette Smoking and Other Tobacco Use; 4 Marketing Policies; 5 Reducing Harm to Smokers: Methods, Their Effectiveness, and the Role of Policy; 6 Reducing the Supply of Tobacco to Youths; 7 The Third Wave of Tobacco Tort Litigation; 8 Clean Indoor Air Restrictions: Progress and Promise; 9 International Aspects of Tobacco Control and the Proposed WHO Treaty; Index; A; B; C; D; E; F; G; H; I; J; L; M; N; O; P; Q; R 327 $aST; U; V; W; Y 330 8 $aThe essays in this text analyse specific strategies used to influence tobacco use, including taxation, regulation of advertising and promotion, regulation of indoor smoking, & sets them against the latest scientific findings about tobacco use. 410 0$aOxford scholarship online. 606 $aTobacco habit$zUnited States 606 $aTobacco habit$zUnited States$xPrevention 606 $aSmoking$xLaw and legislation$zUnited States 606 $aHealth and Wellbeing$2ukslc 615 0$aTobacco habit 615 0$aTobacco habit$xPrevention. 615 0$aSmoking$xLaw and legislation 615 7$aHealth and Wellbeing. 676 $a362.29/66/0973 702 $aRabin$b Robert L. 702 $aSugarman$b Stephen D. 801 0$bStDuBDS 801 1$bStDuBDS 801 2$bStDuBDSZ 801 2$bStDuBDSZ 906 $aBOOK 912 $a9910973361603321 996 $aRegulating tobacco$91042829 997 $aUNINA